Core Points - Allergan Aesthetics, an AbbVie company, announced the seventh annual BOTOX Cosmetic Day on November 19, 2025, celebrating the brand's success and its loyal customers [1][3] - BOTOX Cosmetic is the original FDA-approved treatment for improving the appearance of moderate to severe frown lines, crow's feet, forehead lines, and platysma bands in adults [1][13] - The event will feature exclusive offers through the All loyalty program, which has eight million members and provides rewards for various aesthetic treatments [4][5] Offers and Promotions - On BOTOX Cosmetic Day, members can participate in a buy one, get one free gift card promotion, where purchasing a $50 gift card will yield an additional $50 gift card [6][7] - Members who register, book a consultation, and complete a treatment by December 12 will have a chance to win $25,000 [7][8] Customer Satisfaction and Brand Legacy - A significant majority of patients reported satisfaction with their treatment results, with many stating that BOTOX Cosmetic provides natural-looking results [9] - The brand is recognized as the number one selling product in its category, with 95% of aesthetic specialists choosing BOTOX for themselves and their families [3][4] Company Background - Allergan Aesthetics develops and markets a portfolio of leading aesthetic brands and products, focusing on innovation and exceptional service [11] - AbbVie aims to deliver innovative medicines and solutions across various therapeutic areas, including aesthetics [12]

Group 1 - Visionary Holdings Inc. has announced a strategic partnership with Jiangsu Yike Regenerative Medicine, a leading regenerative medical research institute in China [1] - This partnership aims to leverage technology-driven solutions in the field of regenerative medicine [1] - The collaboration is expected to enhance research capabilities and expand market reach for both companies [1] Group 2 - The partnership signifies a growing trend in the biotechnology sector, focusing on innovative medical solutions [1] - Visionary Holdings Inc. is positioned to benefit from advancements in regenerative medicine through this alliance [1] - The collaboration may lead to new investment opportunities in the healthcare and biotechnology industries [1]